Personalised Medicine Market in Europe

Personalised Medicine Market in Europe

 

RELEASE DATE
17-Feb-2011
REGION
North America
Research Code: M668-01-00-00-00
SKU: HC01907-NA-MR_06956
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC01907-NA-MR_06956

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

The following 44 slides provide an analysis of key trends and issues of the personalised medicine industry globally with a key focus on issues pertaining to Europe. The study provides an overview of the key drivers, restraints and challenges that the personalised healthcare industry faces. It also provides a list of over 100 companies and their areas of focus in the personalised medicine ambit in addition to 30 deals.

Table of Contents

Overview of Personalised Medicine

  • The Blockbuster Model
  • Introduction to Personalised Medicine
  • Role of Biomarkers in Personalised Medicine
  • Drug Development and Companion Diagnostic Development Pathways

Stakeholder Analysis

  • Key Stakeholders and Benefits
  • Analysis of Stakeholder Priorities
  • Comparison of Value of Drug Versus Diagnostic to Stakeholders

Drivers Restraints and Challenges

  • Benefits and Drivers
  • Restraints and Challenges

Personalised Medicine in Europe

  • Main Challenges to Personalised Medicine in EU
  • Regulatory and Reimbursement Issues in Europe
  • Recent Initiatives in Personalised Medicine in Europe

Companies List and Alliances

  • Global List of Companies by Type of Focus
  • Global Pharma Diagnostic Alliances between 2000 and 2010
  • Key Observations
  • Major Themes that have Emerged in Personalised Medicine
  • About Frost & Sullivan
The following 44 slides provide an analysis of key trends and issues of the personalised medicine industry globally with a key focus on issues pertaining to Europe. The study provides an overview of the key drivers, restraints and challenges that the personalised healthcare industry faces. It also provides a list of over 100 companies and their areas of focus in the personalised medicine ambit in addition to 30 deals.
More Information
No Index No
Podcast No
Industries Healthcare
WIP Number M668-01-00-00-00
Is Prebook No